IGHG COVID-19 Statement 

Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus.

The IGHG COVID-19 working group developed a statement to provide guidance to childhood, adolescent and young adult cancer survivors related to risk and additional preventive measures for COVID-19. 

We are updating the statement as soon as new knowledge is available.

Version 3.0 of the statement is now published in English, Dutch, German, French, Italian, Czech, Greek, Polish, Portuguese, Spanish, Croatian, Slovene, Turkish, Chinese, Japanese and Hindi. 

Please find here the IGHG COVID-19 statement:


The publication by Verbruggen et al. (2020) is now published in Pediatric Blood & Cancer



The International Late Effects of Childhood Cancer Guideline Harmonization Group, IGHG, is a worldwide endeavor initiated by several national guideline groups and the Cochrane Childhood Cancer Group in partnership with the PanCare Guidelines Group to collaborate in guideline development.

Our main goal is to establish a common vision and integrated strategy for the surveillance of chronic health problems and subsequent cancers in childhood, adolescent, and young adult cancer survivors.

By international collaboration in guideline development we aim to reduce duplication of effort, optimize the quality of care, and improve quality of life for childhood, adolescent, and young adult cancer survivors.

We welcome all individuals who are willing to contribute to this initiative.

Read more



Logo_zonder schaduw